Viewing Study NCT01959334

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-04-13 @ 1:01 AM
Study NCT ID: NCT01959334
Status: COMPLETED
Last Update Posted: 2019-09-06
First Post: 2013-10-05
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Evaluate the Immunogenicity of a Novel Glucagon Formulation
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Drug-specific Antibodies View
None Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus View
None Hypoglycemia View
None Glucagon View
None Anti-glucagon Antibody View
None Immunogenicity View